Intrinsiqs

Is Cogent Biosciences, Inc. overvalued?

Cogent Biosciences, Inc. (COGT) — key valuation metrics and fundamentals.

No verdict
Price
$37.73
Fair value
Current P/E
Normal P/E
Market cap
$6.45B
Dividend yield
0.0%
Return on equity
-72.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares COGT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.